Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Eli Lilly (LLY) PT Raised to $1,158 at Morgan Stanley
October 11, 2024 8:23 AM EDTMorgan Stanley analyst Terence Flynn raised the price target on Eli Lilly (NYSE: LLY) to $1,158.00 (from $1,106.00) while maintaining a Overweight rating.... More
Eli Lilly (LLY) PT Raised to $1,033 at Truist Securities
October 10, 2024 7:05 AM EDT(Updated - October 10, 2024 7:06 AM EDT)
Truist Securities analyst Robyn Karnauskas raised the price target on Eli Lilly (NYSE: LLY) to $1,033.00 (from $1,000.00) while maintaining a Buy rating.
The analyst commented: "Eli Lilly Model Update, PT goes to $1,033 from $1,000. We... More
